jump to navigation

Cancer Newsletter from Biocompare (29 August 2008) August 29, 2008

Posted by hiiroki in Biotech News.
Tags: , , , , , , , , , , ,
trackback

Courtesy of Biocompare.

News
Gene that Causes Childhood Cancer Neuroblastoma is Found
more…

CSHL Scientists Identify New Drug Target against Virulent Type of Breast Cancer
more…

Normalizing Tumor Vessels to Improve Cancer Therapy
more…

Dense Tissue Promotes Aggressive Cancers
more…

Going from Ulcers to Cancer
more…

To Protect Against Liver Disease, Body Puts Cells ‘Under Arrest’
more…

Anti-Tumor Effects are Enhanced by Inhibiting 2 Pathways Rather than 1
more…

Cancer Therapy: A Role for MAPK Inhibitors Combined with Mtorc1 Inhibitors
more…

Drugs to Inhibit Blood Vessel Growth Show Promise in Rat Model of Deadly Brain Tumor
more…

Researchers Discover Scent of Skin Cancer
more…

New Insights into the Regulation of PTEN Tumor Suppression Function
more…

Stem Cell Indicator for Bowel Cancer Should Lead to Better Survival Rates
more…

Events
Stem Cells, Cancer and Aging
September 22 – September 27, 2008

more…

13th Annual Drug Delivery Summit
September 22 – September 23, 2008
Now in its 13th year, the Annual Drug Delivery Summit has become the industry standard for senior executives and scientists seeking to stay abreast of the latest developments in the drug delivery marketplace, as well as unparalleled networking opportunities. Program highlights include: * Discussing key metrics that define the drug delivery marketplace * Big Pharma’s future plans and expectations for drug delivery * What’s in the pipeline – What’s on the shelf – What’s coming off patent? * Protecting products through early life-cycle management strategies * Innovative, compound-enabling technologies * Overcoming most common challenges in drug delivery * Nanomedicine’s impact on drug delivery And much more! Don’t miss this opportunity to join senior executives and scientists from leading pharmaceutical, drug delivery, biotechnology, biopharmaceutical and specialty pharmaceutical companies to network on current opportunities!
more…

Cancer Degradome Symposium
October 8 – October 9, 2008
Organized by Gillian Murphy, Hideaki Nagase, Dylan Edwards and Abcam
Topics: The status of proteinases as targets in Cancer, Model systems to study the role of proteinases, In vivo imaging, In vitro Biology and Imaging, Multifarious roles of proteinases, Novel translational studies
Speakers: Carol Blobel, Matthew Bogyo, Thomas H. Bugge, Vincent Dive, Suzanne A. Eccles, Alicia Garcia Arroyo, Agnès Noël, Thomas Reinheckel, Carlos López Otín, Yasunori Okada, Paul Saftig, Bonnie Sloane, Katarine Wolf
more…

Jobs
Cytogenetics Sr Research Tech
Memorial Sloan-Kettering Cancer Center
New York USA
more…
Scientist: Medicinal Chemistry Small Molecule & Drug Discovery
Genentech, Inc
California USA
more…
Associate Research Scientist – Post-Doctoral – Experimental Therapeutics -(RF)
OMRF – Oklahoma Medical Research Foundation
Oklahoma USA
more…
Senior Research Technologist
St. Jude Children’s Research Hospital
Tennessee USA
more…

Comments»

No comments yet — be the first.